STERIS kuala ketil, malaysia x-ray operations recieve ISO 13485 accreditations

July 12, 2023

  • Accreditation includes gamma, X-ray, and ethylene oxide processing
  • Allows additional radiation processing capacity in Asia

July 2023 - Earlier this year, STERIS announced the addition of X-ray sterilization services at our existing Kuala Ketil, Malaysia gamma and ethylene oxide facility. As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the Kuala Ketil facility has now received its updated ISO 13485 accreditation to include X-ray processing. To view a copy of our certificate, please go here.

The Kuala Ketil facility is the first X-ray processing location in the APAC region, providing additional radiation processing capacity for medical device and pharmaceutical manufacturers in the region. We are also adding X-ray processing capacity to our existing Chonburi I, Thailand gamma facility, which was previously announced in 2021.

In addition to the new X-ray facility in Kuala Ketil, we support medical device manufacturing in Malaysia through our existing ethylene oxide, electron beam, gamma, and microbiological testing services in Kulim, Port Klang, and Rawang. We also recently announced the addition of ethylene oxide processing through a new site being constructed in Batu Kawan, Malaysia.

Increased demand in medical device manufacturing has accelerated our plans for global expansion. The continued expansion of processing options throughout our global network allows us to support Customers with both routine services and processing redundancy.

STERIS_AST_LocationExpansion_KualaKetil_FBLI_R1.0_101922-300x158

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.
STERIS is pleased to announce our brooklyn park mn usa laboratory iso 17025 accreditation now incl
November 21, 2024
November 21, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory ISO 17025 accreditation now includes product and package testing services.